Published in The New England Journal of Medicine. Peer-reviewed. Large sample size. Sound methodology. An antiviral pill has, for the first time, been shown to prevent COVID-19 in individuals exposed to SARS-CoV-2. Ensitrelvir blocks the enzyme coronaviruses need to make new copies of themselves.
Drug arrives years after pandemic’s peak, but could still offer protection to vulnerable populations.
